title: Intestinal transplantation in children under FK 506 immunosuppression.
abstract: Intestinal transplantation, solitary (n = 3) or in combination with the liver (n = 7), was performed in 10 pediatric patients with intestinal failure. The liver was only replaced if there was liver failure and portal hypertension. Immunosuppression was based on FK 506. Two patients died, one of graft-versus-host disease and one of lymphoproliferative disease. One patient as still in the intensive care unit 1 month posttransplantation due to perioperative complications. The function of the intestinal grafts in the remaining patients is normal. All nutrition and medications including immunosuppression are being administered enterally. This series indicates that small bowel transplantation, alone or in combination with the liver, is feasible in pediatric patients.
authors.affiliation: Department of Surgery, University of Pittsburgh, PA 15213.
authors.forename: A G
authors.initials: AG
authors.lastname: Tzakis
authors.forename: S
authors.initials: S
authors.lastname: Todo
authors.forename: J
authors.initials: J
authors.lastname: Reyes
authors.forename: B
authors.initials: B
authors.lastname: Nour
authors.forename: K
authors.initials: K
authors.lastname: Abu-Elmagd
authors.forename: R
authors.initials: R
authors.lastname: Selby
authors.forename: A
authors.initials: A
authors.lastname: Casavilla
authors.forename: S
authors.initials: S
authors.lastname: Kocoshis
authors.forename: A J
authors.initials: AJ
authors.lastname: Demetris
authors.forename: E
authors.initials: E
authors.lastname: Yunis
mesh_terms: D002648:Child; D002675:Child, Preschool; D005260:Female; D006084:Graft Rejection / Q000276:immunology / Q000517:prevention & control*; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods*; D007223:Infant; D007421:Intestine, Small / Q000276:immunology / Q000637:transplantation*; D016031:Liver Transplantation / Q000276:immunology / Q000379:methods*; D008297:Male; D010289:Parenteral Nutrition, Total; D011183:Postoperative Complications / Q000209:etiology; D016559:Tacrolimus / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D016559:Tacrolimus